0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Varbenazine Capsules Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-38J18239
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Varbenazine Capsules Market Research Report 2024
BUY CHAPTERS

Global Varbenazine Capsules Market Research Report 2024

Code: QYRE-Auto-38J18239
Report
November 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

The global Varbenazine Capsules market was valued at US$ 1840 million in 2023 and is anticipated to reach US$ 4145 million by 2030, witnessing a CAGR of 11.7% during the forecast period 2024-2030.

Varbenazine Capsules Market

Varbenazine Capsules Market

Valbenazine capsules are a medication approved for the treatment of tardive dyskinesia, a condition characterized by involuntary, repetitive movements that can develop as a side effect of long-term antipsychotic medication use. Valbenazine works as a vesicular monoamine transporter 2 (VMAT2) inhibitor, which helps reduce excessive dopamine release in certain brain regions, decreasing the severity of these abnormal movements.
North American market for Varbenazine Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Varbenazine Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Varbenazine Capsules include Neurocrine Biosciences, Sandoz, Teva Pharmaceuticals, Lupin, Zydus, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Varbenazine Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varbenazine Capsules.
The Varbenazine Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Varbenazine Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varbenazine Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Varbenazine Capsules Market Report

Report Metric Details
Report Name Varbenazine Capsules Market
Accounted market size in 2023 US$ 1840 million
Forecasted market size in 2030 US$ 4145 million
CAGR 11.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 40mg per Unit
  • 60mg per Unit
  • 80mg per Unit
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Neurocrine Biosciences, Sandoz, Teva Pharmaceuticals, Lupin, Zydus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Varbenazine Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Varbenazine Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Varbenazine Capsules Market growing?

Ans: The Varbenazine Capsules Market witnessing a CAGR of 11.7% during the forecast period 2024-2030.

What is the Varbenazine Capsules Market size in 2030?

Ans: The Varbenazine Capsules Market size in 2030 will be US$ 4145 million.

Who are the main players in the Varbenazine Capsules Market report?

Ans: The main players in the Varbenazine Capsules Market are Neurocrine Biosciences, Sandoz, Teva Pharmaceuticals, Lupin, Zydus

What are the Application segmentation covered in the Varbenazine Capsules Market report?

Ans: The Applications covered in the Varbenazine Capsules Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Varbenazine Capsules Market report?

Ans: The Types covered in the Varbenazine Capsules Market report are 40mg per Unit, 60mg per Unit, 80mg per Unit

Recommended Reports

Capsule Products

Depression Treatments

Related Disease Therapy

1 Varbenazine Capsules Market Overview
1.1 Product Definition
1.2 Varbenazine Capsules by Type
1.2.1 Global Varbenazine Capsules Market Value Comparison by Type (2024-2030)
1.2.2 40mg per Unit
1.2.3 60mg per Unit
1.2.4 80mg per Unit
1.3 Varbenazine Capsules by Application
1.3.1 Global Varbenazine Capsules Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Varbenazine Capsules Market Size Estimates and Forecasts
1.4.1 Global Varbenazine Capsules Revenue 2019-2030
1.4.2 Global Varbenazine Capsules Sales 2019-2030
1.4.3 Global Varbenazine Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Varbenazine Capsules Market Competition by Manufacturers
2.1 Global Varbenazine Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Varbenazine Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Varbenazine Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Varbenazine Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Varbenazine Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Varbenazine Capsules, Product Type & Application
2.7 Global Key Manufacturers of Varbenazine Capsules, Date of Enter into This Industry
2.8 Global Varbenazine Capsules Market Competitive Situation and Trends
2.8.1 Global Varbenazine Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Varbenazine Capsules Players Market Share by Revenue
2.8.3 Global Varbenazine Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Varbenazine Capsules Market Scenario by Region
3.1 Global Varbenazine Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Varbenazine Capsules Sales by Region: 2019-2030
3.2.1 Global Varbenazine Capsules Sales by Region: 2019-2024
3.2.2 Global Varbenazine Capsules Sales by Region: 2025-2030
3.3 Global Varbenazine Capsules Revenue by Region: 2019-2030
3.3.1 Global Varbenazine Capsules Revenue by Region: 2019-2024
3.3.2 Global Varbenazine Capsules Revenue by Region: 2025-2030
3.4 North America Varbenazine Capsules Market Facts & Figures by Country
3.4.1 North America Varbenazine Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Varbenazine Capsules Sales by Country (2019-2030)
3.4.3 North America Varbenazine Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Varbenazine Capsules Market Facts & Figures by Country
3.5.1 Europe Varbenazine Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Varbenazine Capsules Sales by Country (2019-2030)
3.5.3 Europe Varbenazine Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Varbenazine Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Varbenazine Capsules Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Varbenazine Capsules Sales by Region (2019-2030)
3.6.3 Asia Pacific Varbenazine Capsules Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Varbenazine Capsules Market Facts & Figures by Country
3.7.1 Latin America Varbenazine Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Varbenazine Capsules Sales by Country (2019-2030)
3.7.3 Latin America Varbenazine Capsules Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Varbenazine Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Varbenazine Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Varbenazine Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Varbenazine Capsules Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Varbenazine Capsules Sales by Type (2019-2030)
4.1.1 Global Varbenazine Capsules Sales by Type (2019-2024)
4.1.2 Global Varbenazine Capsules Sales by Type (2025-2030)
4.1.3 Global Varbenazine Capsules Sales Market Share by Type (2019-2030)
4.2 Global Varbenazine Capsules Revenue by Type (2019-2030)
4.2.1 Global Varbenazine Capsules Revenue by Type (2019-2024)
4.2.2 Global Varbenazine Capsules Revenue by Type (2025-2030)
4.2.3 Global Varbenazine Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Varbenazine Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Varbenazine Capsules Sales by Application (2019-2030)
5.1.1 Global Varbenazine Capsules Sales by Application (2019-2024)
5.1.2 Global Varbenazine Capsules Sales by Application (2025-2030)
5.1.3 Global Varbenazine Capsules Sales Market Share by Application (2019-2030)
5.2 Global Varbenazine Capsules Revenue by Application (2019-2030)
5.2.1 Global Varbenazine Capsules Revenue by Application (2019-2024)
5.2.2 Global Varbenazine Capsules Revenue by Application (2025-2030)
5.2.3 Global Varbenazine Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Varbenazine Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Neurocrine Biosciences
6.1.1 Neurocrine Biosciences Company Information
6.1.2 Neurocrine Biosciences Description and Business Overview
6.1.3 Neurocrine Biosciences Varbenazine Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Neurocrine Biosciences Varbenazine Capsules Product Portfolio
6.1.5 Neurocrine Biosciences Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Company Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Varbenazine Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Varbenazine Capsules Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Teva Pharmaceuticals
6.3.1 Teva Pharmaceuticals Company Information
6.3.2 Teva Pharmaceuticals Description and Business Overview
6.3.3 Teva Pharmaceuticals Varbenazine Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceuticals Varbenazine Capsules Product Portfolio
6.3.5 Teva Pharmaceuticals Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Company Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Varbenazine Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Varbenazine Capsules Product Portfolio
6.4.5 Lupin Recent Developments/Updates
6.5 Zydus
6.5.1 Zydus Company Information
6.5.2 Zydus Description and Business Overview
6.5.3 Zydus Varbenazine Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zydus Varbenazine Capsules Product Portfolio
6.5.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Varbenazine Capsules Industry Chain Analysis
7.2 Varbenazine Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Varbenazine Capsules Production Mode & Process
7.4 Varbenazine Capsules Sales and Marketing
7.4.1 Varbenazine Capsules Sales Channels
7.4.2 Varbenazine Capsules Distributors
7.5 Varbenazine Capsules Customers
8 Varbenazine Capsules Market Dynamics
8.1 Varbenazine Capsules Industry Trends
8.2 Varbenazine Capsules Market Drivers
8.3 Varbenazine Capsules Market Challenges
8.4 Varbenazine Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Varbenazine Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Varbenazine Capsules Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Varbenazine Capsules Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Varbenazine Capsules Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Varbenazine Capsules Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Varbenazine Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Varbenazine Capsules Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Varbenazine Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Varbenazine Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Varbenazine Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Varbenazine Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Varbenazine Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Varbenazine Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varbenazine Capsules as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Varbenazine Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Varbenazine Capsules Sales by Region (2019-2024) & (K Units)
 Table 18. Global Varbenazine Capsules Sales Market Share by Region (2019-2024)
 Table 19. Global Varbenazine Capsules Sales by Region (2025-2030) & (K Units)
 Table 20. Global Varbenazine Capsules Sales Market Share by Region (2025-2030)
 Table 21. Global Varbenazine Capsules Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Varbenazine Capsules Revenue Market Share by Region (2019-2024)
 Table 23. Global Varbenazine Capsules Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Varbenazine Capsules Revenue Market Share by Region (2025-2030)
 Table 25. North America Varbenazine Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Varbenazine Capsules Sales by Country (2019-2024) & (K Units)
 Table 27. North America Varbenazine Capsules Sales by Country (2025-2030) & (K Units)
 Table 28. North America Varbenazine Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Varbenazine Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Varbenazine Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Varbenazine Capsules Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Varbenazine Capsules Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Varbenazine Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Varbenazine Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Varbenazine Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Varbenazine Capsules Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Varbenazine Capsules Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Varbenazine Capsules Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Varbenazine Capsules Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Varbenazine Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Varbenazine Capsules Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Varbenazine Capsules Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Varbenazine Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Varbenazine Capsules Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Varbenazine Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Varbenazine Capsules Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Varbenazine Capsules Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Varbenazine Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Varbenazine Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Varbenazine Capsules Sales (K Units) by Type (2019-2024)
 Table 51. Global Varbenazine Capsules Sales (K Units) by Type (2025-2030)
 Table 52. Global Varbenazine Capsules Sales Market Share by Type (2019-2024)
 Table 53. Global Varbenazine Capsules Sales Market Share by Type (2025-2030)
 Table 54. Global Varbenazine Capsules Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Varbenazine Capsules Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Varbenazine Capsules Revenue Market Share by Type (2019-2024)
 Table 57. Global Varbenazine Capsules Revenue Market Share by Type (2025-2030)
 Table 58. Global Varbenazine Capsules Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Varbenazine Capsules Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Varbenazine Capsules Sales (K Units) by Application (2019-2024)
 Table 61. Global Varbenazine Capsules Sales (K Units) by Application (2025-2030)
 Table 62. Global Varbenazine Capsules Sales Market Share by Application (2019-2024)
 Table 63. Global Varbenazine Capsules Sales Market Share by Application (2025-2030)
 Table 64. Global Varbenazine Capsules Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Varbenazine Capsules Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Varbenazine Capsules Revenue Market Share by Application (2019-2024)
 Table 67. Global Varbenazine Capsules Revenue Market Share by Application (2025-2030)
 Table 68. Global Varbenazine Capsules Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Varbenazine Capsules Price (US$/Unit) by Application (2025-2030)
 Table 70. Neurocrine Biosciences Company Information
 Table 71. Neurocrine Biosciences Description and Business Overview
 Table 72. Neurocrine Biosciences Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Neurocrine Biosciences Varbenazine Capsules Product
 Table 74. Neurocrine Biosciences Recent Developments/Updates
 Table 75. Sandoz Company Information
 Table 76. Sandoz Description and Business Overview
 Table 77. Sandoz Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sandoz Varbenazine Capsules Product
 Table 79. Sandoz Recent Developments/Updates
 Table 80. Teva Pharmaceuticals Company Information
 Table 81. Teva Pharmaceuticals Description and Business Overview
 Table 82. Teva Pharmaceuticals Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Teva Pharmaceuticals Varbenazine Capsules Product
 Table 84. Teva Pharmaceuticals Recent Developments/Updates
 Table 85. Lupin Company Information
 Table 86. Lupin Description and Business Overview
 Table 87. Lupin Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Lupin Varbenazine Capsules Product
 Table 89. Lupin Recent Developments/Updates
 Table 90. Zydus Company Information
 Table 91. Zydus Description and Business Overview
 Table 92. Zydus Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Zydus Varbenazine Capsules Product
 Table 94. Zydus Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Varbenazine Capsules Distributors List
 Table 98. Varbenazine Capsules Customers List
 Table 99. Varbenazine Capsules Market Trends
 Table 100. Varbenazine Capsules Market Drivers
 Table 101. Varbenazine Capsules Market Challenges
 Table 102. Varbenazine Capsules Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Varbenazine Capsules
 Figure 2. Global Varbenazine Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Varbenazine Capsules Market Share by Type: 2023 & 2030
 Figure 4. 40mg per Unit Product Picture
 Figure 5. 60mg per Unit Product Picture
 Figure 6. 80mg per Unit Product Picture
 Figure 7. Global Varbenazine Capsules Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Varbenazine Capsules Market Share by Application: 2023 & 2030
 Figure 9. Hospital and Clinic
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Varbenazine Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Varbenazine Capsules Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Varbenazine Capsules Sales (2019-2030) & (K Units)
 Figure 15. Global Varbenazine Capsules Average Price (US$/Unit) & (2019-2030)
 Figure 16. Varbenazine Capsules Report Years Considered
 Figure 17. Varbenazine Capsules Sales Share by Manufacturers in 2023
 Figure 18. Global Varbenazine Capsules Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Varbenazine Capsules Players: Market Share by Revenue in Varbenazine Capsules in 2023
 Figure 20. Varbenazine Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Varbenazine Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Varbenazine Capsules Sales Market Share by Country (2019-2030)
 Figure 23. North America Varbenazine Capsules Revenue Market Share by Country (2019-2030)
 Figure 24. United States Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Varbenazine Capsules Sales Market Share by Country (2019-2030)
 Figure 27. Europe Varbenazine Capsules Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Varbenazine Capsules Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Varbenazine Capsules Revenue Market Share by Region (2019-2030)
 Figure 35. China Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Varbenazine Capsules Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Varbenazine Capsules Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Varbenazine Capsules Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Varbenazine Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Varbenazine Capsules by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Varbenazine Capsules by Type (2019-2030)
 Figure 54. Global Varbenazine Capsules Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Varbenazine Capsules by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Varbenazine Capsules by Application (2019-2030)
 Figure 57. Global Varbenazine Capsules Price (US$/Unit) by Application (2019-2030)
 Figure 58. Varbenazine Capsules Value Chain
 Figure 59. Varbenazine Capsules Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart